(Q37416129)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Michael Rudnicki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

463-476

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

A CRYSTALLINE PRESSOR SUBSTANCE (ANGIOTONIN) RESULTING FROM THE REACTION BETWEEN RENIN AND RENIN-ACTIVATOR

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

The preparation, purification, and amino acid sequence of a polypeptide renin substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

The paradox of the renin-angiotensin system in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Angiotensin II and the pathophysiology of cardiovascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Efficacy and variability of the antiproteinuric effect of ACE inhibition by lisinopril.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Pharmacogenomics of angiotensin converting enzyme inhibitors in renal disease--pathophysiological considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Prognostic effect of insertion/deletion polymorphism of the ace gene on renal and cardiovascular clinical outcomes in Chinese patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Dia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Angiotensin I-converting enzyme gene polymorphism in non-diabetic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Different frequencies of angiotensin-converting enzyme genotypes in older hypertensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Antihypertensive therapy in the presence of proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Effect of VDR gene polymorphisms on osteocalcin secretion in calcitriol-stimulated human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

The influence of the ACE ( I/D) polymorphism on systemic and renal vascular responses to angiotensins in normotensive, normoalbuminuric Type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Antiproteinuric effect of candesartan cilexetil in Japanese subjects with type 2 diabetes and nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Molecular basis of human hypertension: role of angiotensinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Influence of gender and genetic variability on plasma angiotensin peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Genetic polymorphisms of the renin-angiotensin system in end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Polymorphism of renin-angiotensin system genes in IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Effects of the Genetic Polymorphisms of the Renin-Angiotensin System on Focal Segmental Glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Association between Angiotensin-Converting Enzyme Gene Polymorphisms and Diabetic Nephropathy: Case-Control, Haplotype, and Family-Based Study in Three European Populations

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

Amino-Acid Sequence in a Hypertensin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.10.3.463

10.2217/14622416.10.3.463

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19290794%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference